v3.26.1
Note 4 - Business Combination (Details Textual) - Evoke Neuroscience, Inc. [Member]
$ / shares in Units, $ in Thousands
4 Months Ended
Apr. 30, 2025
USD ($)
Rate
$ / shares
Apr. 30, 2025
USD ($)
Rate
$ / shares
Payments to Acquire Businesses, Gross $ 3,000  
Business Combination, Consideration Transferred, Equity Interest $ 3,000  
Business Combination, Price Per Share (in dollars per share) | $ / shares $ 3.5 $ 3.5
Business Combination, Contingent Consideration, Liability $ 478 $ 478
Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount $ 500 500
Business Combination, Acquiree's Revenue since Acquisition Date, Actual   514
Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual   $ (256)
Measurement Input, Discount Rate [Member]    
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.036 0.036
Measurement Input, Discount Rate [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]    
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.035 0.035
Measurement Input, Assumed Income Tax Rate [Member]    
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.265 0.265
Measurement Input, Assumed Income Tax Rate [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]    
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.265 0.265
Measurement Input, Price Volatility [Member]    
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.024 0.024
Measurement Input, Price Volatility [Member] | Valuation Technique, Monte Carlo Pricing Model [Member]    
Business Combination, Contingent Consideration, Liability, Measurement Input (Rate) | Rate 0.016 0.016
Earn Out Shares [Member]    
Business Combination, Contingent Consideration, Liability $ 500 $ 500
Business Combination, Contingent Consideration, Earnout Period (Month) 36 months 36 months